Published in J Comp Neurol on November 13, 1995
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med (2000) 7.05
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology (2003) 3.62
Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron (1994) 2.84
Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett (1989) 2.69
Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci (1998) 2.54
Molecular cloning of the receptor for human antidiuretic hormone. Nature (1992) 2.44
The DBP gene is expressed according to a circadian rhythm in the suprachiasmatic nucleus and influences circadian behavior. EMBO J (1997) 2.17
Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study. Brain Res (1991) 1.76
Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science (1997) 1.76
Cortical inhibition and gamma-aminobutyric acid. Exp Brain Res (1969) 1.74
Action potentials and release of neurohypophysial hormones in vitro. J Physiol (1971) 1.69
Cefotaxime-hydrolysing beta lactamases in Morganella morganii. Eur J Clin Microbiol Infect Dis (1999) 1.67
Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J Neurosci (1995) 1.61
Neuroanatomic correlates of visual agnosia in Alzheimer's disease: a clinicopathologic study. Neurology (1999) 1.61
Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways. Vision Res (1997) 1.59
An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia (1992) 1.49
A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathol (1992) 1.49
Selective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain. J Cereb Blood Flow Metab (1996) 1.48
Diagnosis of Helicobacter pylori infection: noninvasive methods compared to invasive methods and evaluation of two new tests. Am J Gastroenterol (2001) 1.47
Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography. Brain Res (1988) 1.46
Evaluation of the Andromas matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of aerobically growing Gram-positive bacilli. J Clin Microbiol (2012) 1.45
Balint's syndrome in Alzheimer's disease: specific disruption of the occipito-parietal visual pathway. Brain Res (1989) 1.43
Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathol (1992) 1.38
Selective disconnection of specific visual association pathways in cases of Alzheimer's disease presenting with Balint's syndrome. J Neuropathol Exp Neurol (1990) 1.36
Molecular cloning and expression of a fifth muscarinic acetylcholine receptor. J Biol Chem (1989) 1.35
The activity of identified supraoptic neurones and their response to acetylcholine applied by iontophoresis. J Physiol (1972) 1.33
Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia. Neurology (2007) 1.31
Recurrent inhibition of antidromically identified rat supraoptic neurones. J Physiol (1972) 1.28
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. J Clin Invest (1996) 1.28
[Studies of the transmission of excitation in the ventricle of the rat by means of hypertonic solutions]. Pflugers Arch Gesamte Physiol Menschen Tiere (1966) 1.27
The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities. FEBS Lett (1998) 1.27
Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol (1994) 1.26
125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand. Eur J Pharmacol (1988) 1.25
Excitation of phasically firing hypothalamic supraoptic neurones by carotid occlusion in rats. J Physiol (1976) 1.22
Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease. Neuroscience (2003) 1.22
Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch Neurol (1995) 1.22
Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis. Mol Cell (2001) 1.21
Identification and neuron specific expression of the S182/presenilin I protein in human and rodent brains. J Neurosci Res (1996) 1.20
Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol (1992) 1.18
Clinical validity of Braak neuropathological staging in the oldest-old. Acta Neuropathol (2000) 1.17
Excitation of phasically firing supraoptic neurones during vasopressin release. Nature (1975) 1.17
Neuropathological observations in a case of autism presenting with self-injury behavior. Acta Neuropathol (1991) 1.16
Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease. Acta Neuropathol (1994) 1.16
Appearance and transient expression of oxytocin receptors in fetal, infant, and peripubertal rat brain studied by autoradiography and electrophysiology. J Neurosci (1989) 1.16
Vascular dementia. A clinicopathological study. J Neurol Sci (1990) 1.15
Possible neuroprotective role of clusterin in Alzheimer's disease: a quantitative immunocytochemical study. Acta Neuropathol (1998) 1.14
Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res Brain Res Rev (1997) 1.14
Extra-hypothalamic afferent inputs to the supraoptic nucleus area of the rat as determined by retrograde and anterograde tracing techniques. Neuroscience (1985) 1.13
Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem (1999) 1.12
The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions. J Biol Chem (1995) 1.11
Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin. FEBS Lett (1996) 1.09
Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience (2002) 1.08
Review: Contact sport-related chronic traumatic encephalopathy in the elderly: clinical expression and structural substrates. Neuropathol Appl Neurobiol (2011) 1.07
Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol (1998) 1.06
A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease. Brain Res (1987) 1.06
A functional genomic study to identify differential gene expression in the preterm and term human myometrium. Biol Reprod (2003) 1.05
Stimulatory action of oxytocin on neurones of the dorsal motor nucleus of the vagus nerve. Brain Res (1984) 1.04
Pharmacological characterization of two specific binding sites for neurohypophyseal hormones in hippocampal synaptic plasma membranes of the rat. EMBO J (1985) 1.03
Phasically firing neurons in long-term cultures of the rat hypothalamic supraoptic area: pacemaker and follower cells. Brain Res (1979) 1.02
Release of neurohypophysial hormones by exocytosis. Nat New Biol (1973) 1.02
Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients. Arch Neurol (1995) 1.00
Localization of oxytocin binding sites in the human brainstem and upper spinal cord: an autoradiographic study. Brain Res (1989) 1.00
Distinct patterns of neuronal loss and Alzheimer's disease lesion distribution in elderly individuals older than 90 years. J Neuropathol Exp Neurol (1996) 1.00
Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: retrospective clinicopathological evaluation of a 10-year autopsy population. Acta Neuropathol (1994) 1.00
Antidromic inhibition of identified rat supraoptic neurones. Brain Res (1970) 0.99
Oxytocin receptors in the central nervous system. Distribution, development, and species differences. Ann N Y Acad Sci (1992) 0.99
Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience (2006) 0.98
Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci (2000) 0.98
The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease. Neuropathol Appl Neurobiol (2013) 0.98
An anatomic substrate for visual disconnection in Alzheimer's disease. Ann N Y Acad Sci (1991) 0.97
Effects on the isolated neurohypophysis of agents which affect the membrane permeability to calcium. J Physiol (1973) 0.97
Localization of neurones projecting to the hypothalamic paraventricular nucleus area of the rat: a horseradish peroxidase study. Neuroscience (1981) 0.97
Immediate causes of death of demented and non-demented elderly. Acta Neurol Scand Suppl (2000) 0.96
Neurons in the dorsal motor nucleus of the vagus nerve are excited by oxytocin in the rat but not in the guinea pig. Proc Natl Acad Sci U S A (1987) 0.96
The role of central adrenergic receptors in the reflex release of oxytocin. Brain Res (1978) 0.96
Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect. Endocrinology (1995) 0.95
Neuropathological analysis of an asymptomatic adult case with Dandy-Walker variant. Neuropathol Appl Neurobiol (2006) 0.95
Alzheimer's disease with asymmetric atrophy of the cerebral hemispheres: morphometric analysis of four cases. Acta Neuropathol (1994) 0.95
Posterior cortical atrophy in Alzheimer's disease: analysis of a new case and re-evaluation of a historical report. Acta Neuropathol (1993) 0.95
[3H]-[Thr4,Gly7]OT: a highly selective ligand for central and peripheral OT receptors. Am J Physiol (1988) 0.95
Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology (1997) 0.94
The neuropathological changes associated with normal brain aging. Histol Histopathol (1996) 0.94
Appearance and transient expression of vasopressin and oxytocin receptors in the rat brain. J Recept Res (1991) 0.94
Contrasting effects of neurohypophysial peptides on pyramidal and non-pyramidal neurones in the rat hippocampus. Brain Res (1984) 0.94
Selective vulnerability of neocortical association areas in Alzheimer's disease. Microsc Res Tech (1998) 0.94
Characterization of a uterine-type oxytocin receptor in the rat hippocampus. Proc Natl Acad Sci U S A (1983) 0.94
Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family. Cell Mol Neurobiol (1995) 0.93
Multiple actions of acetylcholine on hippocampal pyramidal cells in organotypic explant cultures. Neuroscience (1982) 0.93
[3H]vasopressin binding to rat hippocampal synaptic plasma membrane. Kinetic and pharmacological characterization. FEBS Lett (1983) 0.93